Skip to main content
SpringerLink
Log in

Isorhapontigenin Suppresses Interleukin-1β-Induced Inflammation and Cartilage Matrix Damage in Rat Chondrocytes

  • Original Article
  • Published:
Inflammation Aims and scope Submit manuscript

Abstract

Osteoarthritis (OA) is a common cause of joint pain and physical disability in the elderly. It is highly associated with local inflammatory reactions and cartilage degradation. Isorhapontigenin (ISO), a natural compound existing in various plants, has shown prominent anti-inflammatory and anti-oxidative properties in several inflammatory diseases. However, the effects of ISO on OA remain to be elucidated. Here, we investigated the effects of ISO on interleukin-1β (IL-1β)-treated rat chondrocytes and cartilage explants. Our results revealed that ISO could suppress the IL-1β-induced elevated levels of nitric oxide (NO), inducible nitric oxide synthase (iNOS), prostaglandin E2 (PGE2), and cyclooxygenase-2 (COX2). Besides, ISO could also inhibit the IL-1β-induced up-regulation of cartilage matrix catabolic enzymes such as matrix metalloproteinases (MMPs) and aggrecanase-2 (ADAMTS5). Moreover, the IL-1β-induced downregulation of collagen II and aggrecan could be reversed by ISO. Furthermore, ISO prevented rat cartilage explant damage induced by IL-1β. Mechanistically, ISO worked partly by suppressing mitogen-activated protein kinase (MAPK)-associated ERK and p38 pathways. Taken together, our study indicated the anti-inflammatory potential of ISO on IL-1β-treated rat chondrocytes, providing a new idea for OA treatment.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7

Similar content being viewed by others

References

  1. Mathiessen, A., and P.G. Conaghan. 2017. Synovitis in osteoarthritis: current understanding with therapeutic implications. Arthritis Research & Therapy 19 (1): 18.

    Article  Google Scholar 

  2. Aicher, W.K., and B. Rolauffs. 2014. The spatial organisation of joint surface chondrocytes: review of its potential roles in tissue functioning, disease and early, preclinical diagnosis of osteoarthritis. Annals of the Rheumatic Diseases 73 (4): 645–653.

    Article  Google Scholar 

  3. Troeberg, L., and H. Nagase. 2012. Proteases involved in cartilage matrix degradation in osteoarthritis. Biochimica et Biophysica Acta 1824 (1): 133–145.

    Article  CAS  Google Scholar 

  4. Glyn-Jones, S., A.J.R. Palmer, R. Agricola, A.J. Price, T.L. Vincent, H. Weinans, and A.J. Carr. 2015. Osteoarthritis. Lancet 386 (9991): 376–387.

    Article  CAS  Google Scholar 

  5. Bonnet, C.S., and D.A. Walsh. 2005. Osteoarthritis, angiogenesis and inflammation. Rheumatology (Oxford) 44 (1): 7–16.

    Article  CAS  Google Scholar 

  6. Dodge, G.R., and A.R. Poole. 1989. Immunohistochemical detection and immunochemical analysis of type II collagen degradation in human normal, rheumatoid, and osteoarthritic articular cartilages and in explants of bovine articular cartilage cultured with interleukin 1. The Journal of Clinical Investigation 83 (2): 647–661.

    Article  CAS  Google Scholar 

  7. Le Maitre, C.L., et al. 2007. Matrix synthesis and degradation in human intervertebral disc degeneration. Biochemical Society Transactions 35 (Pt 4): 652–655.

    PubMed  Google Scholar 

  8. Goldring, S.R., and M.B. Goldring. 2004. The role of cytokines in cartilage matrix degeneration in osteoarthritis. Clinical Orthopaedics and Related Research (427 Suppl): S27–S36.

    Article  Google Scholar 

  9. Chabane, N., N. Zayed, H. Afif, L. Mfuna-Endam, M. Benderdour, C. Boileau, J. Martel-Pelletier, J.P. Pelletier, N. Duval, and H. Fahmi. 2008. Histone deacetylase inhibitors suppress interleukin-1beta-induced nitric oxide and prostaglandin E2 production in human chondrocytes. Osteoarthritis and Cartilage 16 (10): 1267–1274.

    Article  CAS  Google Scholar 

  10. Wang, Q.L., M. Lin, and G.T. Liu. 2001. Antioxidative activity of natural isorhapontigenin. Japanese Journal of Pharmacology 87 (1): 61–66.

    Article  CAS  Google Scholar 

  11. Yeo, S.C.M., P.S. Fenwick, P.J. Barnes, H.S. Lin, and L.E. Donnelly. 2017. Isorhapontigenin, a bioavailable dietary polyphenol, suppresses airway epithelial cell inflammation through a corticosteroid-independent mechanism. British Journal of Pharmacology 174 (13): 2043–2059.

    Article  CAS  Google Scholar 

  12. Kawakami, S., Y. Kinoshita, H. Maruki-Uchida, K. Yanae, M. Sai, and T. Ito. 2014. Piceatannol and its metabolite, isorhapontigenin, induce SIRT1 expression in THP-1 human monocytic cell line. Nutrients 6 (11): 4794–4804.

    Article  Google Scholar 

  13. Liu, Y., and G. Liu. 2004. Isorhapontigenin and resveratrol suppress oxLDL-induced proliferation and activation of ERK1/2 mitogen-activated protein kinases of bovine aortic smooth muscle cells. Biochemical Pharmacology 67 (4): 777–785.

    Article  CAS  Google Scholar 

  14. Oh, J.S., I.A. Cho, K.R. Kang, J.S. You, S.J. Yu, G.J. Lee, Y.S. Seo, C.S. Kim, D.K. Kim, S.G. Kim, Y.W. Seo, H.J. Im, and J.S. Kim. 2016. Biochanin-A antagonizes the interleukin-1beta-induced catabolic inflammation through the modulation of NFkappaB cellular signaling in primary rat chondrocytes. Biochemical and Biophysical Research Communications 477 (4): 723–730.

    Article  CAS  Google Scholar 

  15. Chen, P., S. Zhu, Y. Wang, Q. Mu, Y. Wu, Q. Xia, X. Zhang, H. Sun, J. Tao, H. Hu, P. Lu, and H. Ouyang. 2014. The amelioration of cartilage degeneration by ADAMTS-5 inhibitor delivered in a hyaluronic acid hydrogel. Biomaterials 35 (9): 2827–2836.

    Article  CAS  Google Scholar 

  16. Wojdasiewicz, P., L.A. Poniatowski, and D. Szukiewicz. 2014. The role of inflammatory and anti-inflammatory cytokines in the pathogenesis of osteoarthritis. Mediators of Inflammation 2014: 561459.

    Article  Google Scholar 

  17. Su, S.C., K. Tanimoto, Y. Tanne, R. Kunimatsu, N. Hirose, T. Mitsuyoshi, Y. Okamoto, and K. Tanne. 2014. Celecoxib exerts protective effects on extracellular matrix metabolism of mandibular condylar chondrocytes under excessive mechanical stress. Osteoarthritis and Cartilage 22 (6): 845–851.

    Article  CAS  Google Scholar 

  18. Dragos, D., M. Gilca, L. Gaman, A. Vlad, L. Iosif, I. Stoian, and O. Lupescu. 2017. Phytomedicine in joint disorders. Nutrients 9 (1): 70.

    Article  Google Scholar 

  19. Abbas, A.M. 2016. Cardioprotective effect of resveratrol analogue isorhapontigenin versus omega-3 fatty acids in isoproterenol-induced myocardial infarction in rats. Journal of Physiology and Biochemistry 72 (3): 469–484.

    Article  CAS  Google Scholar 

  20. Dai, Y., S.C.M. Yeo, P.J. Barnes, L.E. Donnelly, L.C. Loo, and H.S. Lin. 2018. Pre-clinical pharmacokinetic and metabolomic analyses of isorhapontigenin, a dietary resveratrol derivative. Frontiers in Pharmacology 9: 753.

    Article  CAS  Google Scholar 

  21. Roos, E.M., and N.K. Arden. 2016. Strategies for the prevention of knee osteoarthritis. Nature Reviews Rheumatology 12 (2): 92–101.

    Article  CAS  Google Scholar 

  22. Attur, M., I. Belitskaya-Lévy, C. Oh, S. Krasnokutsky, J. Greenberg, J. Samuels, S. Smiles, S. Lee, J. Patel, H. al-Mussawir, G. McDaniel, V.B. Kraus, and S.B. Abramson. 2011. Increased interleukin-1beta gene expression in peripheral blood leukocytes is associated with increased pain and predicts risk for progression of symptomatic knee osteoarthritis. Arthritis and Rheumatism 63 (7): 1908–1917.

    Article  CAS  Google Scholar 

  23. Wang, P., et al. 2018. Histone deacetylase-4 and histone deacetylase-8 regulate interleukin-1beta-induced cartilage catabolic degradation through MAPK/JNK and ERK pathways. International Journal of Molecular Medicine 41 (4): 2117–2127.

    CAS  PubMed  PubMed Central  Google Scholar 

  24. Cao, M., et al. 1997. Nitric oxide inhibits the synthesis of type-II collagen without altering Col2A1 mRNA abundance: prolyl hydroxylase as a possible target. The Biochemical Journal 324 (Pt 1): 305–310.

    Article  CAS  Google Scholar 

  25. Takada, K., et al. 2013. Endoplasmic reticulum stress mediates nitric oxide-induced chondrocyte apoptosis. Biomedical Reports 1 (2): 315–319.

    Article  CAS  Google Scholar 

  26. Dumond, H., N. Presle, P. Pottie, S. Pacquelet, B. Terlain, P. Netter, A. Gepstein, E. Livne, and J.Y. Jouzeau. 2004. Site specific changes in gene expression and cartilage metabolism during early experimental osteoarthritis. Osteoarthritis and Cartilage 12 (4): 284–295.

    Article  CAS  Google Scholar 

  27. Vo, N.V., R.A. Hartman, T. Yurube, L.J. Jacobs, G.A. Sowa, and J.D. Kang. 2013. Expression and regulation of metalloproteinases and their inhibitors in intervertebral disc aging and degeneration. The Spine Journal 13 (3): 331–341.

    Article  Google Scholar 

  28. Saklatvala, J. 2007. Inflammatory signaling in cartilage: MAPK and NF-kappaB pathways in chondrocytes and the use of inhibitors for research into pathogenesis and therapy of osteoarthritis. Current Drug Targets 8 (2): 305–313.

    Article  CAS  Google Scholar 

  29. Sondergaard, B.C., N. Schultz, S.H. Madsen, A.C. Bay-Jensen, M. Kassem, and M.A. Karsdal. 2010. MAPKs are essential upstream signaling pathways in proteolytic cartilage degradation—divergence in pathways leading to aggrecanase and MMP-mediated articular cartilage degradation. Osteoarthritis and Cartilage 18 (3): 279–288.

    Article  Google Scholar 

  30. Cargnello, M., and P.P. Roux. 2011. Activation and function of the MAPKs and their substrates, the MAPK-activated protein kinases. Microbiology and Molecular Biology Reviews 75 (1): 50–83.

    Article  CAS  Google Scholar 

Download references

Acknowledgments

This study was supported by the grant from the National Natural Science Foundation of China (no. 51537004) to H.W.

Author information

Author notes

  1. Yongzhuang Ma and Chang Tu contributed equally to this work.

Authors and Affiliations

  1. Department of Orthopedics, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, People’s Republic of China

    Yongzhuang Ma, Chang Tu & Hua Wu

  2. Department of Pathology and Pathophysiology, School of Medicine, Jianghan University, Wuhan, Hubei, People’s Republic of China

    Wei Liu & Yifan Xiao

Authors
  1. Yongzhuang Ma
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Chang Tu
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Wei Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Yifan Xiao
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Hua Wu
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding authors

Correspondence to Yifan Xiao or Hua Wu.

Ethics declarations

This study was in strict accordance with the Guidelines of Animal Care and Use Committee for Teaching and Research of Huazhong University of Science and Technology, Wuhan, China.

Conflict of Interest

The authors have no conflict of interest or financial disclosures with this research.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ma, Y., Tu, C., Liu, W. et al. Isorhapontigenin Suppresses Interleukin-1β-Induced Inflammation and Cartilage Matrix Damage in Rat Chondrocytes. Inflammation 42, 2278–2285 (2019). https://doi.org/10.1007/s10753-019-01092-0

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10753-019-01092-0

KEY WORDS

Search

Navigation